Simplex Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-129
| Closed | -$43K | – | 8388 |
|
|
2018
Q3 | $43K | Sell |
129
-51
| -28% | -$184 | ﹤0.01% | 5326 |
|
|
2018
Q2 | $67K | Sell |
180
-57
| -24% | -$278 | ﹤0.01% | 4747 |
|
|
2018
Q1 | $9K | Sell |
237
-310
| -57% | -$1.44K | ﹤0.01% | 4186 |
|
|
2017
Q4 | $30K | Sell |
547
-292
| -35% | -$1.61K | ﹤0.01% | 2943 |
|
|
2017
Q3 | $134K | Sell |
839
-61
| -7% | -$439 | 0.01% | 1484 |
|
|
2017
Q2 | $158K | Buy |
900
+258
| +40% | +$1.61K | 0.01% | 1386 |
|
|
2017
Q1 | $62K | Buy |
642
+374
| +140% | +$2.05K | ﹤0.01% | 2177 |
|
|
2016
Q4 | $33K | Buy |
268
+69
| +35% | +$377 | ﹤0.01% | 2585 |
|
|
2016
Q3 | $12K | Buy |
199
+138
| +226% | +$744 | ﹤0.01% | 3489 |
|
|
2016
Q2 | $4K | Sell |
61
-87
| -59% | -$486 | ﹤0.01% | 4539 |
|
|
2016
Q1 | $28K | Sell |
148
-163
| -52% | -$651 | ﹤0.01% | 2494 |
|
|
2015
Q4 | $18K | Buy |
311
+164
| +112% | +$779 | ﹤0.01% | 2806 |
|
|
2015
Q3 | $1K | Buy |
147
+16
| +12% | +$107 | ﹤0.01% | 5288 |
|
|
2015
Q2 | $13K | Buy |
+131
| New | +$1.41K | ﹤0.01% | 2870 |
|
|
2015
Q1 | – | Sell |
-139
| Closed | -$21K | – | 5981 |
|
|
2014
Q4 | $21K | Buy |
+139
| New | +$2.15K | ﹤0.01% | 2028 |
|
Simplex Trading's KERX Position: Q4 2018 in Review
Simplex Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 5,600 shares — an estimated $19K sold.
Simplex Trading first reported a position in KERX in Q1 2015 and held it in 9 quarters. The position peaked at $153K in Q3 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Simplex Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Simplex Trading sold 5,600 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $19K.
- Simplex Trading first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 9 quarters.
- Simplex Trading's Keryx Biopharmaceuticals Inc position peaked at $153K in Q3 2016.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Simplex Trading's 13F filing for Q4 2018, filed 16 Jan 2019.